Intermittent Fasting for NAFLD in Adults

Abroad (travel likely)Recruiting

Conditions

Fatty Liver · Intermittent Fasting · Fatty Liver, Nonalcoholic · Non-Alcoholic Fatty Liver Disease · Liver Fat

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Kathleen E Corey, MD/MPH) · kathleen.corey@mgh.harvard.edu · 6177265925
Contact: Study coordinator (Megan Michta, BA) · mmichta@mgh.harvard.edu · 6176439458

Study leads

Kathleen Corey, MD
Principal Investigator
Massachusetts General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population

Fatty Liver

Abroad (travel likely)Recruiting

Dallas, United States

Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter

Fatty Liver

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong

NAC- NAFLD And Cushing

Cushing Syndrome · Fatty Liver Disease

Abroad (travel likely)Recruiting

Angers, France · Bordeaux, France

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Non-alcoholic Fatty Liver Disease

Abroad (travel likely)RecruitingPHASE3

Arcadia, United States · Covina, United States